Quick Answer
TriSalus Life Sciences, Inc. reported Total Revenue of $45.15 million for the year ending 2025.
- TriSalus Life Sciences, Inc. showed an increase of +53.4% in Total Revenue from 2024 to 2025.
- This data is from TriSalus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $3.92 million | Q1 2023: $2.98 million | Q2 2023: $4.61 million | Q3 2023: $5.19 million | Q1 2024: $6.46 million | Q2 2024: $7.36 million | Q3 2024: $7.35 million | Q1 2025: $9.17 million | Q2 2025: $11.21 million | Q3 2025: $11.57 million.
- Over the full 4 years of available data (2022 to 2025), TriSalus Life Sciences, Inc.'s Total Revenue has grown by 264.2%.
- Historical annual values: Fiscal year 2025: $45.15 million | Fiscal year 2024: $29.43 million | Fiscal year 2023: $18.51 million | Fiscal year 2022: $12.40 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: